http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006014429-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c438b93bd3fb45ab54bdef6bbf5f113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_652f577940a3c17d7795b5af0c58d6c7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-556
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-657181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65742
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6512
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-02
filingDate 2005-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c82e38d3e2b159e69fb77766dae2bd52
publicationDate 2006-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006014429-A3
titleOfInvention Cidofovir peptide conjugates as prodrugs
abstract Cidofovir-based compounds having an amino acid, dipeptide or tripeptide attached to a cidofovir or cyclic cidofovir framework. The compounds show enhanced oral bioavailability and increased binding to the PepT1 transporter. The present invention also provides compositions and methods for treating virus infections, and a method of preparing cidofovir.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108586363-B
priorityDate 2004-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5922695-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415822763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554402
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009186
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID793301
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6564
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122873
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID117261

Total number of triples: 40.